Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
10
NCT03096340
Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 23, 2017
Completion: Nov 26, 2019